1 Division of Critical Care Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.
2 Division of Pediatric Neurological Surgery, Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN.
3 Department of Pharmacy, Monroe Carell Jr Children’s Hospital at Vanderbilt, Nashville, TN.
4 Vanderbilt University, Nashville, TN.
5 Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.
6 Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.
7 Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN.
8 Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN.
*See also p. 677.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
Dr. Betters’ institution received funding from the National Institutes of Health (R61HL151951). Dr. Wellons disclosed the off-label product use of ketamine for intracranial pressure. Dr. Slaughter received funding from the Department of Pediatrics for statistical support. The remaining authors have disclosed that they do not have any potential conflicts of interest.
For information regarding this article, E-mail: [email protected]